![Ted Smolenski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ted Smolenski
Corporate Officer/Principal at Putney, Inc.
Profile
Ted Smolenski is currently working as Vice President-Business Development & Portfolio at Putney, Inc. Previously, he worked as Director-Portfolio Management at Impax Laboratories LLC and as Principal at Merck & Co., Inc. He completed his undergraduate degree and MBA from the University of Delaware.
Ted Smolenski active positions
Companies | Position | Start |
---|---|---|
Putney, Inc.
![]() Putney, Inc. Pharmaceuticals: MajorHealth Technology Putney, Inc. operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets. It offers human-approved generic drugs such as ampicillin sodium for injection, cefpodoxime proxetil tablets and amoxicillin trihydrate capsules. The firm also provides injectables, carprofen caplets and dermatological therapeutics. The company was founded by Jean Hoffman in 2006 and is headquartered in Portland, ME. | Corporate Officer/Principal | - |
Former positions of Ted Smolenski
Companies | Position | End |
---|---|---|
MERCK & CO., INC. | Corporate Officer/Principal | - |
Impax Laboratories LLC
![]() Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Training of Ted Smolenski
University of Delaware | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private companies | 2 |
---|---|
Putney, Inc.
![]() Putney, Inc. Pharmaceuticals: MajorHealth Technology Putney, Inc. operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets. It offers human-approved generic drugs such as ampicillin sodium for injection, cefpodoxime proxetil tablets and amoxicillin trihydrate capsules. The firm also provides injectables, carprofen caplets and dermatological therapeutics. The company was founded by Jean Hoffman in 2006 and is headquartered in Portland, ME. | Health Technology |
Impax Laboratories LLC
![]() Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Ted Smolenski